Physician profile
Robert L Simons
NPI 1528175940
$3,971.55
in general payments reported to CMS, 2019-2025
12 companies · $47.16 in 2025
The $47.16 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,056 · 2020: $473 · 2021: $1,945 · 2022: $406 · 2024: $44.46 · 2025: $47.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $91.62.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $91.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,528.90 | 2019-2025 | Niagara Lateral Access System |
| Globus Medical, INC. | $1,276.28 | 2019-2022 | |
| Nuvasive, INC. | $816.94 | 2019-2020 | |
| Alphatec Spine, INC | $127.12 | 2022 | |
| Choice Spine, LLC | $65.07 | 2020 | |
| Zimmer Biomet Holdings, INC. | $48.11 | 2020 | |
| Spinal Elements, INC. | $22.11 | 2022 | |
| Depuy Synthes Sales INC. | $21.66 | 2019 | |
| Aesculap, INC. | $18.50 | 2019 | |
| Vifor Pharma, INC. | $17.23 | 2019 | |
| Boston Scientific Corporation | $15.21 | 2020 | |
| Medtronic USA, INC. | $14.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Simons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.